Twice-weekly Grand Rounds enable clinicians to present complex cases live within a multidisciplinary consortium of ...

The MarketWatch News Department was not involved in the creation of this content. -- The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z ...

The researchers found that patients who received high-risk rounds were less likely to incur a hospital-acquired condition, compared with those who did not receive rounds. HealthDay News — Implementing ...

The Series A extension rounds will help advance global clinical development for the company's two leading programs with distinct competitive advantages. ALK201, a potential first- and best-in-class ...